Sulfonylurea Receptor 1 in Central Nervous System Injury: An Updated Review
Sulfonylurea receptor 1 (SUR1) is a member of the adenosine triphosphate (ATP)-binding cassette (ABC) protein superfamily, encoded by Abcc8, and is recognized as a key mediator of central nervous system (CNS) cellular swelling via the transient receptor potential melastatin 4 (TRPM4) channel. Discov...
Saved in:
Main Authors: | Ruchira M. Jha, Anupama Rani, Shashvat M. Desai, Sudhanshu Raikwar, Sandra Mihaljevic, Amanda Munoz-Casabella, Patrick M. Kochanek, Joshua Catapano, Ethan Winkler, Giuseppe Citerio, J. Claude Hemphill, W. Taylor Kimberly, Raj Narayan, Juan Sahuquillo, Kevin N. Sheth, J. Marc Simard |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b4cbc90795874d4aba03952cb01d898c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
by: Kunavisarut T, et al.
Published: (2019) -
Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus
by: Lyudmila Viktorovna Nedosugova
Published: (2013) -
Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
by: Alla Vsevolodovna Rudakova
Published: (2011) -
Feasibility of efficacious therapy of diabetes mellitus by sulfonylurea agents in neonates with KCNJII gene mutation: originalobservation
by: Andrey Olegovich Emel'yanov, et al.
Published: (2009) -
The frequency of hypoglycemia and cardiovascular disorders during therapy with sulfonylureas compared with other secretagogues: a systematic review
by: Aleksey Vadimovich Zilov, et al.
Published: (2010)